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Endograft infection leading to rupture of aortic
aneurysm
Jose R. Parra, MD,a Calvin Lee, MD,b Kim J. Hodgson, MD,b and Bruce Perler, MD,a Baltimore, Md;
and Springfield, Ill
Aortic endografting has quickly been accepted as a less morbid method of aneurysm repair. However, preservation of the
aortic sac after endografting remains a liability of this procedure. Late rupture has occurred, albeit rarely. Graft infections
are another rare complication of endografting. We present the first reported case, to our knowledge, of aortic rupture
secondary to infection of an aortic endograft. (J Vasc Surg 2004;39:676-8.)Aortic endografting has quickly achieved widespread
use as a safer alternative to the repair of abdominal aortic
aneurysms. Aside from obvious differences in the manner in
which the graft is placed, the technique of aortic endograft-
ing differs significantly from open repair in that the aneu-
rysm sac is preserved. The persistence of the aneurysm sac
creates a lifelong liability that mandates periodic surveil-
lance. There are relatively few data regarding long-term
outcomes or complications. Infection of aortic endografts
is rare. We report aortic rupture after endografting that was
associated with infection of the endograft.
CASE REPORT
An 85-year-old man with a history of chronic obstructive
pulmonary disease and weight loss had a 7-cm abdominal aortic
aneurysm (AAA). Angiography confirmed an infrarenal AAA with
a proximal neck 18 mm long and 22 mm in diameter. The iliac
arteries were mildly ectatic but not aneurysmal. After thorough
evaluation and preoperative preparation, including confirmation of
no demonstrable infection, the patient underwent placement of a
26  15  13.5-cm AneuRx bifurcated aortic endograft
(Medtronic/AVE, Santa Rosa, Calif). The entire graft was affixed
in place with a high-volume, compliant balloon. Both the proce-
dure and postoperative course were uncomplicated. The patient
was given 1 g of cephazolin sodium (Ancef) antibiotic preopera-
tively. The procedure was performed with the patient under local
anesthesia with monitored sedation. Postoperatively the white
blood cell count was normal, and the patient had no fever. The
aneurysm sac remained stable in size over the next few years, with
no evidence of endoleak, and the patient was followed up with
computed tomography (CT) every 6 months to 1 year. The last CT
scan was obtained 1 month before presentation (Fig 1).
Approximately 2 years after endograft implantation, the pa-
tient was seen at a local emergency room, with severe abdominal
and back pain of 1 week’s duration. The patient was emaciated, but
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doi:10.1016/j.jvs.2003.09.048676hemodynamically stable, with a diffusely tender abdomen and a
prominent, pulsatile abdominal mass. A CT scan demonstrated a
6.8-cm aneurysm with significant eccentricity and fat stranding
along the anterolateral wall (Fig 1). There were no endoleaks or
evidence of contrast material outside the lumen of the endograft. A
Fig 1. Top, Abdominal CT scan shows the aorta 1 month before
onset of symptoms. All diameters were stable at that time. Bottom,
CT scan obtained during symptomatic phase shows thickening of
the aorta wall, fat stranding, and a contained aneurysm rupture.
There is no evidence of endoleak.
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cell count was 21,000 cells/mm3.
The patient was taken to the operating room for extra-ana-
tomic bypass and removal of a presumptively infected endograft.
After placement of an axillobifemoral bypass graft, the abdomen
was explored. The supraceliac aorta was isolated for eventual clamp
placement. Significant thickening and friability along the antero-
lateral wall of the aneurysm were apparent. A contained rupture
was present along the lateral wall, which when exposed released a
large volume of turbid fluid under pressure. Infected aneurysm
wall and thombus were removed. There was no evidence of en-
doleak on opening the sac. The aorta was clamped, and the
endograft was easily recovered (Fig 2). The aorta and iliac arteries
were oversewn, and the abdomen was vigorously irrigated. Omen-
tum was tacked to the aortic stump. Cultures of the aortic sac fluid
later grew methicillin-sensitive Staphylococcus aureus, and the pa-
tient was given culture-appropriate antibiotics for 6 weeks. The
patient died 1 year after endograft removal, of complications
associated with a bleeding duodenal ulcer. Autopsy was not per-
formed.
DISCUSSION
Reports of infection involving aortic endografts are
rare. Jackson et al,1 in a case report and review of the
subject, identified 11 cases of endograft infection and 8
additional cases of aortoendograft fistula. The current case
adds to the growing body of reports of endograft infection,
and is notable in that the infection progressed rapidly and
produced sufficient pressure to cause rupture of the aortic
sac. There are multiple causes of endograft infection. Con-
tamination of the graft at placement is likely the source of
early infection. Diagnosis of early infection can be difficult.
Post-implantation leukocytosis, fever, and perigraft air oc-
cur frequently and are not associated with early graft infec-
Fig 2. Intraoperative photograph stion.2 Our patient had no postoperative fever or leukocy-
tosis.
Secondary infection from a remote source is another
potential route of infection. Reports have documented the
development of endograft infection in the presence of other
infections, for example, in the urinary tract.1 The presence
of gram-negative organisms within the endograft without
known remote infection also suggests the potential for
hematogenous inoculation.3,4
Several reports have noted aortoenteric fistula after
endografting.5-7 The Vanguard endograft was involved in
most of these infections. Erosion of the stent portion of the
endograft appeared to be the major cause of fistula devel-
opment. We noted in our patient that the iliac arteries had
thinned as a result of expansion of the endograft to the
point where it could be seen through the vessel wall (Fig 3).
This raises the question of whether oversizing of grafts
potentially can lead to endograft erosion.
Aortic endografts may be more susceptible to infection
than grafts placed with traditional open methods. In animal
models, polytetrafluoroethylene (PTFE) endografts appear
to have less resistance to infection and higher concentra-
tions of bacteria than grafts placed at open surgery.8 In
addition, this study found that higher concentrations of
inoculated bacteria resulted in aortic wall rupture. One
possible explanation is that the intact aneurysm wall in a
patient with an endograf prevents any egress and thus
produces a more aggressive “closed space” infection.
The cause of endograft infection with Staphylococcus in
our patient is unclear. The patient was not hospitalized
except for a single instance of treatment of chronic obstruc-
tive pulmonary disease exacerbation between implantation
and the graft infection. He had no other wounds, ulcers, or
other compromise to the skin barrier. The development of
pus leaking from the aneurysm sac.
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of the infection was relatively recent.
Rupture of endografted aneurysms remains a concern.
The incidence of this problem is low, and most cases have
been associated with the presence of an untreated endoleak
or known expansion.9-11 While aneurysm sac expansion is
usually due to pressurization of the sac from exposure to
arterial flow, this is not always the case. Risberg et al12
described four patients in whom aneurysm sac expansion
developed as the result of the presence of a hygroma within
the sac. Our case illustrates that infection should be in-
cluded among the causes of endotension.
This is the first report, to our knowledge, of rupture of
an endografted AAA involving an infected graft. Infection
of endografts can be caused by local or hematogenous
inoculation. Prophylactic antibiotic therapy, such as 2 g of
cephazolin sodium (Ancef) or 1 gram of vancomycin, is
recommended before graft placement and when any type of
invasive procedure is to be undertaken. Recognition or
suspicion of endograft infection requires prompt removal
accompanied by extra-anatomic bypass or in situ recon-
struction.13,14
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